Back

Gut Microbiota Production of Phenylacetate Programs Vascular Niche Senescence and Drives Atherosclerosis

Shabanian, K.; Constancias, F.; Pugin, B.; Shabanian, T.; Thomas, A.; Le Gludic, S.; Spalinger, M.; Mongelli, A.; Menni, C.; Zhang, X.; Da Dalt, L.; Colucci, M.; Cetina Biefer, H. R.; Dzemali, O.; Hermann, M.; Alimonti, A.; Norata, G. D.; Paneni, F.; Ruschitzka, F.; Saeedi Saravi, S. S.

2026-03-02 cell biology
10.64898/2026.02.27.708541 bioRxiv
Show abstract

Vascular senescence is a key contributor to ageing-related diseases, including atherosclerosis. Initial intervention is based on aggressive management of traditional risk factors, yet microbial metabolites remain underestimated as modifiable factors. We recently identified phenylacetate (PAA), a gut microbiota-linked metabolite, as a potent accelerator of endothelial senescence, raising the question of its causal role in atherosclerosis. Here, we show that PAA promotes vascular niche senescence and perivascular adipose tissue (PVAT) dysfunction, associated with atherosclerosis in humans and mice. Furthermore, PAA administration to atherosclerosis-prone mice was sufficient to drive atherosclerosis without altering lipid profile. Mechanistically, we found that PAA induces senescence-messaging secretome, containing IL-6, from endothelial cells, which stimulates Notch1 and disrupts insulin signaling in adipocytes. Blocking the PAA-IL-6-Notch1 axis as well as senolytics rescued adipocyte senescence and dysfunction. Identification of the strong link between PAA and atherosclerosis opens new avenues for microbiome-targeted preventive and therapeutic strategies in ageing. HighlightsO_LIAge-dependent increase in gut microbial metabolite PAA causally promotes vascular niche senescence C_LIO_LIPAA indirectly accelerates PVAT senescence through endothelial senescence-messaging secretome C_LIO_LISASP upregulates Notch1 signaling, leading to PVAT dysfunction C_LIO_LISenolytic therapy restores PVAT function C_LIO_LIPAA-induced vascular niche senescence contributes to atherosclerosis progression C_LI

Matching journals

The top 5 journals account for 50% of the predicted probability mass.

1
Nature Communications
4913 papers in training set
Top 10%
14.5%
2
Nature Aging
51 papers in training set
Top 0.1%
14.2%
3
Developmental Cell
168 papers in training set
Top 1%
12.2%
4
Nature Metabolism
56 papers in training set
Top 0.2%
6.7%
5
Cell Reports
1338 papers in training set
Top 7%
6.3%
50% of probability mass above
6
Nature
575 papers in training set
Top 6%
3.9%
7
Cell Stem Cell
57 papers in training set
Top 0.5%
3.5%
8
Molecular Cell
308 papers in training set
Top 5%
3.2%
9
Cell
370 papers in training set
Top 7%
3.0%
10
The EMBO Journal
267 papers in training set
Top 1%
2.0%
11
Cell Metabolism
49 papers in training set
Top 1.0%
1.8%
12
Cell Host & Microbe
113 papers in training set
Top 3%
1.7%
13
Aging Cell
144 papers in training set
Top 2%
1.7%
14
Immunity
58 papers in training set
Top 3%
1.5%
15
eLife
5422 papers in training set
Top 46%
1.5%
16
Proceedings of the National Academy of Sciences
2130 papers in training set
Top 37%
1.3%
17
Science Advances
1098 papers in training set
Top 22%
1.3%
18
Nature Cell Biology
99 papers in training set
Top 3%
1.2%
19
Circulation
66 papers in training set
Top 2%
1.2%
20
PLOS Biology
408 papers in training set
Top 18%
0.8%
21
Nature Medicine
117 papers in training set
Top 4%
0.8%
22
Cell Chemical Biology
81 papers in training set
Top 3%
0.8%
23
Cell Reports Medicine
140 papers in training set
Top 8%
0.7%
24
Cell Discovery
54 papers in training set
Top 5%
0.7%
25
EMBO reports
136 papers in training set
Top 7%
0.7%
26
Protein & Cell
25 papers in training set
Top 3%
0.6%
27
iScience
1063 papers in training set
Top 38%
0.6%
28
Cell Genomics
162 papers in training set
Top 8%
0.6%